Your AI Doctor Is Coming | Julie Yoo

a16z General Partner Julie Yoo joins MTS host Sophia Dew to explain why she believes healthcare could benefit more from AI than almost any other industry, and why decades of slow technology adoption may actually give healthcare an advantage in the AI era. Julie traces healthcare’s evolution from paper records and fax machines through electronic health records and telehealth, and explains why AI represents something different: an organic adoption wave driven by tools that doctors and patients actually want to use. Because healthcare never built the same layers of legacy software as other industries, it may now be able to leapfrog directly into agentic AI. They also explore how AI could dramatically lower the cost of care, why consumers are becoming a more important payer, where Julie sees the biggest opportunities for healthcare founders, and a future where everyone has a highly personalized AI doctor in their pocket for life.

Speaker names marked ? are inferred from speaking time and the show’s known hosts — they are not voice-verified.

• 0:00Speaker 00

  Healthcare is one of the most expensive industries in the world, yet time and medical expertise remain scarce. Julie Yu thinks AI could change that. The A16Z general partner joins Sophia Du on MTS to explain why healthcare may benefit more from AI than almost any other industry, and why its slow adoption of technology could now be an advantage, allowing it to leapfrog legacy software and move directly to AI-native workflows. Julie also shares where she sees the biggest opportunities for founders, from consumer healthcare and AI-native care delivery, to robotics and new payment models, and why the future could include an AI doctor in your pocket for life.

• 0:42Speaker 01

  Julie, welcome to MTS.

• 0:43Julie Yoo?

  Thanks so much for having me.

• 0:45Speaker 01

  I'm so excited to chat with you and I'm so excited to get into this conversation because often in some of the conversations around AI, people don't totally understand how it affects them. And I think healthcare is one of the most obvious places where you actually get to see that possible. But before we jump into all of the details there, I would love to just start a little bit with your personal story. Why is healthcare one of the big problems you wanted to solve?

• 1:08Julie Yoo?

  Yeah, absolutely. I've been in the healthcare industry now for probably, gosh, 18 years at this point. And I was too early, you know, like back then. I was actually a technologist by training. So out of school was a software engineer in the broader tech ecosystem, wrote code for the first seven years of my career, did a lot in like the early era of like e-commerce and fintech and manufacturing, et cetera. And then made a career change into healthcare right when the federal government was starting to talk about how do we digitize healthcare? Because I'm sure I've talked to anyone about their experience in healthcare. One of the first things they'll say is, "I'm being papered to death. I'm being fax machine to death." We still have a long way to go. But imagine 20 years ago when the majority of the industry was actually still working on paper. Like doctors' offices still had those paper folders in their cabinets and nothing was digitized.

• 1:51Julie Yoo?

  And so the federal government decided to implement this massive program, which is kind of a miraculous program when you think about it. Basically, what they said was, "We will pay doctors, tens of thousands of dollars to implement electronic health records." And that was the way by which our industry sort of came into the modern era was for over the course of about five to seven years, I would say. Literally, 100% of doctors in the US were heads down implementing these kind of system of record, electronic health record platforms. And that's how we kind of came into digitization. So right around then was when I made a career change, thinking, "Okay, I've now seen what great it looks like with respect to enterprise technology being applied to all these other industries, e-commerce, retail, manufacturing, et cetera. Now it's time for healthcare to have its shot in the light." And of course, again, I was like 15, 20 years too early.

• 2:36Julie Yoo?

  But obviously, so much of the evolution that's occurred in the last 10 years is really what I get excited about. And I initially started out in kind of the genomics era, which was one of the first areas where you saw just an explosion of data. We had the Human Genome Project. We now understood the fundamental code of humanity. And there was a whole industry that exploded around kind of computational biology. How does genomics tie to ultimate disease and things of that sort? So did a couple of really cool companies in that area. And then ultimately around 2010 was when I started Kyris, which was my company, really with the thesis of some of what you described. So we as consumers experience extreme access issues when we try to get in touch with the healthcare system. The average wait time for a primary care doctor's appointment is weeks, if not months, in most major cities across the US still today.

• 3:20Julie Yoo?

  And when me and my co-founder started to talk to executives who were running these large hospitals and physician groups in the industry, what we didn't realize was they were telling us, "Yes, people are waiting out the door, but if you actually look at the way that our physicians are being utilized, we're still way under 100%," which was shocking, right? We had this paradox of demand out the door. And yet, when you looked at utilization rates of physicians' time, it was way under 100%. And so that was the thesis behind our company Kyris, was how do you sort of solve this patient access paradox? By creating a single system of appointment inventory across the healthcare system and the ability to route patients to the right doctor and the right appointment in such a way that you could actually effectively utilize that capacity much more efficiently.

• 4:05Julie Yoo?

  And so did that for an amazing nine years as co-founder and CPO. But it was again in the sort of like the stone age of health tech.

• 4:12Speaker 01

  Yeah, more.

• 4:13Julie Yoo?

  This gets to sort of my current job today. Back then was imagine tech sort of like pre-Stripe, pre-all the sort of like API layer of how you build companies and stand-up companies. That was effectively the situation in health tech back then. Very little venture capital also going into our space back then. And a lot of the conventional wisdom at the time was, "Healthcare is just so hard, right? It's a highly regulated industry. Things are super slow. People are understandably conservative because the stakes are very high to, you know, if you get something wrong.

• 4:43Speaker 01

  It's a life, it's a human life, exactly.

• 4:43Julie Yoo?

  If you get something wrong, the stakes are very high. And so there was a reticence to believe that the kind of speed of growth and scale of technology application that you would see in other industries could even happen in healthcare. And so it was not as popular of an industry for VCs to really kind of put their heft behind. So back then, I joked that there was like five guys who like invested in our space and I raised from like all five of them. But, you know, it was pre-APIs. I liken the work that I did literally with my own two hands as taking a chisel and a nail against this concrete wall of integrating into the infrastructure of healthcare. And so it took a lot of time, a lot of capital. It was really hard to recruit talent back then because it just was an unsexy industry, right? If you had a choice of going to Google versus trying to build these 1970s systems,

• 5:28Julie Yoo?

  like why would you choose to come into our space? So we did it the hard way, but great outcome. We actually just sold the company last year.

• 5:33Speaker 01

  Congratulations, that's so huge.

• 5:35Julie Yoo?

  Yeah.

• 5:36Speaker 01

  A decade paid off.

• 5:37Julie Yoo?

  Yeah, it was like a 15-year overnight success. But in that time, so many things occurred to really mature the industry in so many ways that now I would argue this is our moment in health tech. And I've now been an investor. After I stepped down from my company, I came to the dark side and I now run the healthcare investing team at Andreessen. And what's occurred over the last seven years, like literally since I've joined the firm, is really remarkable. So one, obviously, we had COVID, which I think was a huge reason why people were forced to recognize the need to create a digital modality for engaging with the healthcare system. And it really tore apart a lot of the previously held assumptions about how healthcare needs to work in terms of everything from how are physicians credentialed to practice medicine?

• 6:20Julie Yoo?

  Historically, it's been a very sort of local system where we sort of deliberately constrained supply in healthcare in weird ways. So you have to get licensed at the state level. And it was not the case that doctors typically would have a license to practice medicine outside of their state. But with telehealth, all of a sudden, you had this national scale demand for clinical services. And so lots of states and federal agencies had to kind of rethink from first principles. How do we relax some of these constraints to enable people to get access to care when you can no longer go in person? That was one. Another was kind of the way that we pay for healthcare. Telehealth previously was, in many cases, was not paid for unless you had previously had an in-person visit with a doctor. So we had to relax a lot of those roles. So there was a lot of tailwinds in the industry during that period

• 7:03Julie Yoo?

  that sort of led to acceleration of the ability to build tech companies in this space. And then obviously, AI. I mean, I think I've declared loudly that I believe healthcare is the industry that will benefit the most from AI for many reasons that I'm sure we'll talk about. But the level of accelerated growth and scale and adoption that we've now seen in the last, let's call it, three to five years post-AI, I think is proving that point and demonstrating that the moment is here for digital health to be a thing.

• 7:30Speaker 01

  Definitely. It's so fascinating getting to hear your story because you understand how technology has affected the healthcare industry for over multiple decades. And you've got to see when you're way too early, as you say. I like how you mention your 15-year overnight success.

• 7:45Julie Yoo?

  Which most startups are.

• 7:47Speaker 01

  Exactly, most startups are. I'm going to quote that from my parents. I'm like, "No, no, no, I'll be a 15-year overnight success. Just you wait, just you wait." But as you alluded to, healthcare, it's been a long time coming. And this was maybe prior when you were starting your startup. It wasn't as sexy of an industry. It was harder to get talent. It was harder to get capital. But it seems to me that that's no longer the case. Even if what you're seeing with Dario, where he's saying, "Okay, we're doubling down in health. We're going to cure cancer." I talk to startups all of the time, especially in AI. And one of the common themes that we're seeing is that they're going towards the hard problems, the ones that are really bureaucratic, the ones that are legacy, that if you solve it correctly, literally saves hundreds of thousands, millions, billions of lives.

• 8:32Speaker 01

  And so I'm so excited to see that. And I would love to just get your opinion. What shifted? What was the big change over the past few years that gave us this renaissance, this healthcare industry renaissance that we're in?

• 8:44Julie Yoo?

  I think it was a confluence of factors. So I mean, exactly to your point, it's always been the one industry that literally impacts everyone. Every single life has some interaction with the healthcare system at some point. And typically, it's a very negative experience, unfortunately. And so I think one thing is that just consumers have gotten to a certain breaking point where especially as all of the experiences in the rest of our life, right? If you think about how Uber has changed transportation, how Airbnb has changed travel, how Instacart has changed the way we think about food, et cetera, et cetera. Our standard and our bar for what we expect from any service industry has gone way up while healthcare has kind of stayed stagnant. So I think that gap has really gotten to a breaking point where consumers are saying, "I want to vote with my feet and my dollars to get better services wherever I can get them." So that's been one big change.

• 9:28Julie Yoo?

  I think at the same time, the incumbent industry is under extreme siege, right? So if you think about large hospital systems, large insurance companies, employers put the majority of the bill for most insurance fees and premium dollars for a vast majority of Americans. And so all of these organizations are sort of experiencing increased cost structure, right? So labor has gotten much more expensive. Labor has gotten much more constrained. We did unfortunately have a big sort of outflux of talent from the healthcare industry because of COVID, you know, because it was such a stressful and arduous time that a lot of people said, "I'm throwing the towel in and I'm going to go do something else with my medical training." So at the same time, the government has also really come down on the cost, right?

• 10:10Julie Yoo?

  And said, "We have just unsustainable amounts of bloat right now." And this is a little bit of a rathole, but you know, one of the... Reasons that healthcare appears to be so esoteric is that we have this weird third-party payer system, right? Like, the vast majority of your healthcare is not paid for by you. And so you don't necessarily feel the pain with every, you know, dollar that you're spending in the healthcare system. And therefore, there tends to be a lot more bloat than if you would have with like a free-market dynamic. And so, you know, the government's coming down on that. Payers in general are coming down on that. So you have all this cost pressure on the incumbent system that has driven, you know, traditional providers and payers to say, our business model, like, no longer works. Like, the math doesn't math anymore.

• 10:52Julie Yoo?

  And we can't continue to sustain this kind of payment modality. And AI, like, I would say certainly AI, in some ways, was like the straw that broke the back, where, you know, historically, because healthcare is such an esoteric, sort of scarce, training-oriented industry, where you literally have to go to school for, what is it, you know, at least seven years and train and to even become a specialist, you know, service provider in our industry. So the bar to, you know, being able to create technology that could replicate any, anything that's close to that level of expertise has been really difficult. Until we now have this, you know, abundant intelligence, you know, capability that we have with LLMs. And so I think that, you know, those, I would say, are the major confluence of factors

• 11:35Julie Yoo?

  that have now resulted in a recognition by both the supply side and the demand side that things need to change. And, I mean, the last thing I'll say is that one of the ways by which the system had reacted to this kind of cost bloat in the past was to say, okay, if you have, let's say, insurance covered by your employer, you know, historically, the employer covered the majority of the costs and you didn't really feel any of the financial pain. Now, what they started to say, like, a few years ago was, okay, let's actually do some cost shifting. Let's actually give consumers a little bit of skin in the game and say, okay, we're gonna have deductibles. And so up to $1,000, your insurance is not gonna kick in, so anything under that, you're gonna have to pay for. And then that actually is what caused consumers to realize, okay, gosh, I have to pay how much for what kind of crappy services?

• 12:20Julie Yoo?

  And, you know, people really start to feel it directly. And now you have this proliferation of services to kind of fill that void, right? We have amazing companies that you can pay literally $10 per month out of pocket to get incredible, incredible services that, when compared to what you could get for that same amount of dollars with the traditional healthcare system, is just 1,000 times better. And so that's what really, I think, has caused the adoption wave that we've seen by just individuals.

• 12:47Speaker 01

  Oh, interesting. So what I'm hearing is there's some systemic shifts around how healthcare is just paid for, and that's really been changing over the last few years. And then, of course, what exists now with technology and AI. And one of the things that you argued is that healthcare may benefit more from AI than arguably any other industry. And so I wanna just unpack a little bit more about where exactly you can see AI's benefits when it comes to healthcare. One of the areas that we were just talking about yesterday is in discovery of diseases and drug discovery, but there's still a whole development pipeline that doesn't, it doesn't totally benefit the consumer until maybe it goes through a bunch of clinical trials. I know there's a lot of different angles.

• 13:31Speaker 01

  If we could just briefly touch upon the whole stack. Where is AI actually playing? How will I, as a person, as a consumer, as a customer, how will I feel this benefit?

• 13:41Julie Yoo?

  Yeah, absolutely. I'll talk about it in a couple of different ways. One is, the industry itself has been almost like antithetical to technology adoption, historically. We literally have been like the lowest, in terms of dollars spent on, on tech, you know, relative to revenue, like, the lowest, of the lowest in terms of industries. And so, you know, one thing that's changed now is, is kind of this, like, what I call a leapfrog dynamic, where when you think about every other industry, they spent the last, you know, couple of decades laying down, like, workflow SaaS rails, right? Like, software service companies. And they had this whole, sort of like, middleware layer on top of infrastructure that they spent tens of billions of dollars on, trained a whole generation of workers on. And then when AI came along, they said, oh, my God, we have to rip and replace

• 14:23Julie Yoo?

  this whole previous paradigm of technology and replace it with a Gentic AI and retrain our whole generation of workers on that modality. Healthcare for better, for worse, did not spend that amount of money, right? So we only had really, like, the ERP layer with EHRs and then labor. Like, we were just throwing bodies at every problem. And so in some ways, we have less of a sunk cost bias as an industry to say, okay, this new technology paradigm has come along and we can just leap right to it. We don't have to worry about ripping out, you know, 20 years and tens of billions of dollars' worth of middleware software. We can actually just go directly to this agentic form of technology. And that's actually been a huge boon to many of the companies that sell into the space. So the other, I wrote a blog post about a year ago that talked about the fact

• 15:05Julie Yoo?

  that historical eras of technology adoption in healthcare were always very unnatural, like what I talked about earlier. You had to pay doctors to adopt technology. You had to have a pandemic to force people to use telehealth. This is currently is the only, like, the first real organic adoption wave that we've seen in health tech, where doctors are just using AI scribes because they fricking work and they're so good and they really change the nature of their job for the positive. And you're seeing a lot more of this, almost like, PLG-led motion, where individual physicians and frontline workers actually have agency and being able to use these tools in a much different way. So that's one part that's happening more on kind of the enterprise side. On the consumer side, you know, thank you, ChatGPT and Claude.

• 15:46Julie Yoo?

  Like, everybody is going to LLMs for health-related questions, right? And they're pretty damn good, right? And they've gotten a lot better since the early days, when they first came out. Less hallucination, much more, you know, sort of actionable advice and recommendations. And they're starting to, like, forward-integrate into actual marketplaces where you can get advice from ChatGPT and then go book an appointment with a real doctor. And so I think that's just taught a whole generation of humans. There is, number one, just a much more low-friction way to get medical advice, even if the medical advice might not be regulated and licensed and, you know, and fully validated in the way that you would get from doctors. The trade-off is, I either, you know, have to wait four months to get a real doctor's

• 16:29Julie Yoo?

  appointment or go to an emergency room and pay $2,000. Or I can just open up my phone. So I think that trade-off, again, that delta makes it incredibly easy for people to just go to the lowest-friction place. And so I think people, like, consumers are now educated that there's a better way. And now we have a whole wave of new companies, many of which we've invested in, that are taking a specialized approach to how we leverage AI to create consumer experience, consumer-grade experiences, where you're now seeing, like, a company, we have a company called Council Health in our portfolio, which is literally an AI-native doctor practice that is a 24-by-7 asynchronous chat modality with real doctors.

• 17:10Julie Yoo?

  Like, imagine chatting with your chatbot but having an actual licensed MD in the chat who can fully prescribe, who can fully refer, who can fully diagnose. And so you kind of get the best of both worlds of, you know, AI-native care with real doctors who can actually provide clinical utility. And so you're seeing the advent of these new capabilities that literally were not possible even just a few years ago.

• 17:31Speaker 01

  One of the things that just wasn't possible a few years ago that I wanted to bring up, there was this hackathon by Anthropic AI and AWS Cloud. And it was called the Rare Disease Real Kid Hackathon. And they had $50,000 in prizes. And the way that they did it is they actually had a child, they, they uploaded the kid's genome and the clinical data, and they shared it with the community, of course, with parental consent. And people were able to actually understand, yeah, and generate insights. And I saw this and I was, I was, I was amazed. I was, this is so cool. You can actually, for specialist, it's really hard to find specialists, especially for rare diseases.

• 18:15Speaker 01

  Those are, and children with rare diseases, there's so little resources actually going into, the money doesn't actually make sense. And so seeing this, I was like, wow, this is amazing. This is one really clear example of how AI can actually play out, can actually save human lives. Curious to hear what your opinion was of this whole hackathon, if you saw it.

• 18:36Julie Yoo?

  Yeah, no, absolutely. I think every day, I mean, one of the most exciting things is that, like, literally every day on my X feed, I will see 100 examples of something like that. And I think, to me, there's sort of three parts. One is, you know, how do you lower the barrier to access intelligence? Which, again, that, that barrier used to be a real, you know, kind of impediment to people getting access to healthcare. Now that thing, that's really gone away. And then I think now the question moves towards, what do you do about it, right? Once you actually understand a bit more about what your issue might be or what diagnosis you might have, you still need to, number one, get that verified. You might need actual testing or, you know, kind of clinical-grade testing to get, to get it, get it fully diagnosed. You might need to be either prescribed a therapeutic or a procedure or, you know,

• 19:20Julie Yoo?

  get some sort of in-person care. And then there's like the longitudinal aspect of it as well. A lot of the way that people are using, which is great, I mean, medical AI today is highly transactional. Imagine if you can have a doctor for life that's powered by that kind of, you know, modality, we know what that could mean for life. So I think the first bucket is being solved by, you know, a lot of these generalist tools. I think it's really the second and the third bucket, that therein is the opportunity for, you know, health tech builders to really take a crack at that last mile of what do we do about it and how do we stay with you for life until it's resolved, until the next issue comes up, et cetera.

• 19:54Speaker 01

  That's so cool. One thing I wanted to get your opinion on, since now you're on the investor's side, coming from the builder's side to now the investor's side, you, one, have to make a bit of predictions about where things are going to go. And, two, you get to see the opportunity landscape almost at a macro level. And so if someone is coming to you for maybe advice, or there's a founder who is Asking, okay, Julie, where do I go? What are the big opportunities here? What are the big problems that still need solving? What advice would you share?

• 20:27Julie Yoo?

  Yeah. How much time do we have? I mean, there's the opportunity. It's like the best time to be building in this space. I'm so jealous of all my founders who get to be building right now. I think probably a couple that I would highlight that we've written about recently. So folks can kind of check out our theses on this. One is definitely the consumer angle. I joked a few months ago that if you had come to any investor, let's call it, you know, seven years ago and pitched a consumer health business, you would have been kicked out of the room because there was no viable business model. It was not clear that consumers understood and had agency to, you know, really take, take control of their health, et cetera. And, you know, the payment models were not there. So now that all that's changed and some of the fastest growing companies that we see in health tech are,

• 21:11Julie Yoo?

  you know, cash pay, you just pay out of pocket for a service at a disruptively low price. I think that's actually the biggest lever that's changed is even if you could pay for things out of, out of pocket historically, the price was prohibitive. And now because of the, you know, magic of AI, the cost structure to deliver an actual like medically credible service is like a hundred times lower than it used to be. And so you're seeing a whole proliferation of an entirely new marketplace of products that were designed for the consumer, not like historically where you had to design for the insurance company and the doctor. And then consumers almost as an afterthought. Consumers are now at the top of that pile in a really exciting way. So we wrote a piece called Consumers Are The New Payer, basically, to sort of recognize that, that trend.

• 21:56Julie Yoo?

  So that's one big area. Another post that I had just last week, actually, was one where we made the argument that the best companies right now are those that are AI native and AI proof. And it kind of gets to what I was saying earlier, where yes, you can have an amazing, you know, medical, sort of general medical intelligence, LLM, that answers a bunch of questions that, you know, historically you had to go wait for six months to see a specialist to get. But what about the rest of it, right? So how do you actually deliver in-person services to people who can't travel to the hospital? How do you actually do, you know, how do you take a blood draw and actually diagnose? Like what do you actually have? How do you, you know, do all the things that today, at least in our country,

• 22:37Julie Yoo?

  are not like are legal to do, you know, lest you have some sort of regulated entity? So we have a lot of companies that on the outside, and this kind of mirrors a lot of what we saw in the first era of tech, you know, more broadly, where you had kind of these challenger businesses that were full stack in nature. So like from the outside, they might just look like a retailer or just look like some kind of service provider. But on the inside, they were obviously highly AI native and therefore had a surface area that was not achievable, you know, through historical means and a cost structure that was disruptive such that they, they can continue to invest in innovation because they had high margins. We're seeing a ton of companies that are embracing kind of the best of both worlds in that way. So I think AI native, AI proof combination is a lot of where the excitement is.

• 23:22Julie Yoo?

  Hardware companies, you know, are included in that. So I think, you know, robots are like, I think there's product market fit between, you know, what robotics companies can do and what is necessary in really like high acuity healthcare settings. And then the final thing I'll say is like insurance, like the payment rails are, one of the reasons that like, you know, people look at healthcare and they say, oh, it's so screwed up. Like it's so like, why is it so screwed up? I'm like, it's actually designing exactly as planned. Like if you actually study the inner edge of how incentives are aligned based on the payment system that exists in healthcare, it results in exactly what we experienced today. And so there's a lot of really ambitious companies that are saying,

• 24:02Julie Yoo?

  what if we blew up that current healthcare payment modality and built a new one from scratch? And, you know, that is amongst probably the most ambitious things that you could do is kind of build almost like a mini healthcare system in one company. But there's companies like Devoted Health and others who are doing this. And I think now it's possible because again, the cost to entering into building a company in our space has gone down because all this infrastructure now exists. You can do so much more with, with AI. And the appetite from the system, both in terms of consumer customers as well as the traditional ecosystem is there in a way that's never been before.

• 24:38Speaker 01

  Oh, that is so exciting and exciting to hear. My last question for you, what prediction do you have that will be true in a decade from now? I would love to one day, you know, tell my kids or my future kids, yeah, back in my day, healthcare was X and now.

• 24:56Julie Yoo?

  Yeah, yeah.

• 24:56Speaker 01

  And then what do you think?

• 24:57Julie Yoo?

  I mean, I think so, getting to your example about the sort of, you know, roll your own genome analysis thing, like I do think there will be a lot of roll your own healthcare.

• 25:04Speaker 01

  So cool.

• 25:05Julie Yoo?

  Where you will have N of one solutions that are like only like super personalized to you, but still get, you know, the kind of benefit of the broader set of intelligence that everybody's contributing back to. I mean, one of the interesting things about healthcare is that in order to train a model in healthcare, I would argue that we actually don't even have the data sets necessary to truly train like a medical grade AI because we rely heavily today on electronic health record data, which is really sporadic, right? Like how many times you actually go to see a traditional doctor in your life? It's like maybe at best once a year. So there's a whole narrative arc of your experience as a, a patient that is absent from pretty much every data set that exists today. So I think a lot of companies will start doing these kind of N of one experiments

• 25:50Julie Yoo?

  that generate the new data rails that then drive the next generation of models that are built in our space. So I think N of one health is, is a, is a big idea. And I think all of us will genuinely have an AI doctor in our pocket for life.

• 26:04Speaker 01

  Yeah, we'll all have a personalized specialist that knows us better than anything in the world. That is so exciting to see. And this is one of the reasons I am such a big tech optimist and so excited for the future and how technology is impacting the future. And you touched upon directly some very concrete reasons. But Julie, really wanted to thank you for joining us today on MTS.

• 26:23Julie Yoo?

  Absolutely.

• 26:23Speaker 01

  Such a great conversation.

• 26:25Julie Yoo?

  Thanks for having me.

• 26:25Speaker 01

  Thank you so much for joining.

• 26:29Speaker 00

  Thanks for listening to this episode of the A16Z Podcast. If you liked this episode, be sure to like, comment, subscribe, leave us a rating or a review and share it with your friends and family. For more episodes, go to YouTube, Apple Podcasts and Spotify. Follow us on X at A16Z and subscribe to our Substack at a16z.substack.com. Thanks again for listening and I'll see you in the next episode. This information is for educational purposes only and is not a recommendation to buy, hold or sell any investment or financial product. This podcast has been produced by a third party and may include paid promotional advertisements, other company references and individuals unaffiliated with A16Z. Such advertisements, companies and individuals are not endorsed by AH Capital Management LLC,

• 27:14Speaker 00

  A16Z or any of its affiliates. Information is from sources deemed reliable on the date of publication, but A16Z does not guarantee its accuracy.